DeepMed Research

BAYLOR COLLEGE OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1900-10-30

Employees: 10K

Market Cap: -

Website: http://www.bcm.edu

Clinical Trials

An Interactive Web-Based Program to Improve Food and Activity Choices of Teens

Not Applicable

Completed

Conditions: Physical Activity
Diet

Interventions: Other: teen web

First Posted Date: 2009-09-24

Last Posted Date: 2015-03-20

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 400

Registration Number: NCT00983567

Locations: 🇺🇸
Children's Nutrition Research Center, Houston, Texas, United States

Prostate Cancer Symptom Management for Low Literacy Men

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Behavioral: Usual care
Behavioral: PC-PEP - Prostate Cancer Patient Education Program

First Posted Date: 2009-09-24

Last Posted Date: 2018-01-23

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 108

Registration Number: NCT00983710

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Safety Study of Probiotics in Adults With Irritable Bowel Syndrome

Phase 1

Completed

Conditions: Irritable Bowel Syndrome

Interventions: Biological: Probiotic

First Posted Date: 2009-09-04

Last Posted Date: 2016-03-08

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 21

Registration Number: NCT00971711

Locations: 🇺🇸
Baylor Clinic, Houston, Texas, United States
🇺🇸
Univerisity of Washington, Seattle, Washington, United States

Multisite Controlled Trial of Cocaine Vaccine

Phase 2

Completed

Conditions: Cocaine Dependence

Interventions: Other: Placebo Injection
Drug: TA-CD Vaccination

First Posted Date: 2009-09-01

Last Posted Date: 2017-03-15

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 300

Registration Number: NCT00969878

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
Substance Abuse Treatment and Research Service (Downtown), New York, New York, United States
🇺🇸
Cincinnati Addiction Research Center, Cincinnati, Ohio, United States

and more 3 locations

Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes

Phase 2

Completed

Conditions: Nasopharyngeal Carcinoma

Interventions: Drug: Docetaxel
Drug: Carboplatin
Drug: Dexamethasone
Biological: EBV-specific cytotoxic T lymphocytes
Biological: G-CSF or Peg-GCSF

First Posted Date: 2009-08-06

Last Posted Date: 2017-08-18

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 20

Registration Number: NCT00953420

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States

The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes

Phase 4

Completed

Conditions: Type 2 Diabetes

Interventions: Drug: Byetta (exenatide)
Drug: Symlin (pramlintide)

First Posted Date: 2009-08-03

Last Posted Date: 2017-04-24

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 16

Registration Number: NCT00950677

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Umbilical Cord Blood Transplant for Congenital Pediatric Disorders

Not Applicable

Completed

Conditions: Congenital Pediatric Disorders

Interventions: Drug: Busulfan
Drug: Cytoxan
Drug: Fludarabine
Procedure: Cord Blood Stem Cell Infusion

First Posted Date: 2009-08-03

Last Posted Date: 2023-10-30

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 40

Registration Number: NCT00950846

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States

Calmer Life: A Worry Reduction Program for Older Adults

Not Applicable

Completed

Conditions: Anxiety

Interventions: Behavioral: Calmer Life

First Posted Date: 2009-07-03

Last Posted Date: 2018-01-23

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 32

Registration Number: NCT00932178

Locations: 🇺🇸
Michael E DeBakey VA Medical Center, Houston, Texas, United States

Effectiveness of Ultrasound (US) Guided Supraclavicular Block

Not Applicable

Withdrawn

Conditions: Pain
Analgesia

Interventions: Drug: 20 ml of ropivacaine 0.5%
Drug: 30 ml of ropivacaine 0.5%
Drug: 40 ml of ropivacaine 0.5%

First Posted Date: 2009-06-18

Last Posted Date: 2017-01-20

Lead Sponsor: Baylor College of Medicine

Registration Number: NCT00923494

Locations: 🇺🇸
Ben Taub General Hospital, Houston, Texas, United States

A Study of Bevacizumab to Prevent Malignant Ascites

Phase 2

Withdrawn

Conditions: Malignant Ascites

Interventions: Drug: Bevacizumab

First Posted Date: 2009-05-25

Last Posted Date: 2015-06-03

Lead Sponsor: Baylor College of Medicine

Registration Number: NCT00908219

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸
Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, United States
🇺🇸
Ben Taub General Hospital, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy